Correa and Bergman are co-chairs of the congressional Psychedelics Advancing Therapies (PATH) Caucus. Mercer is a Marine Corps veteran and the executive director of Healing Breakthrough.

In people with traumatic brain injury, administering the psychedelic drug ibogaine seems to slow down brainwaves, which may ...

Veterans Affairs officials insist there are no caps on mental health care, but providers in multiple states disagree.

In the United States, stellate ganglion block is FDA-approved for pain management and can be used off-label for PTSD. In ...

Single-cell analyses revealed molecular profiles that can distinguish PTSD from depression, potentially leading to better ...

Bryan Hubbard in 2023 wanted Kentucky to be the first state to study the psychedelic ibogaine to treat opioid addiction, but ...

The new drug has already passed Phase 1 safety trials in humans, making it a "strong candidate" for future PTSD treatments.

Emyria Ltd ( ($AU:EMD) ) has issued an update. Emyria Limited is expanding its Perth clinic to meet the growing demand for PTSD treatments, ...

Successful nonpharmacological treatments are available outside the VA system.

Psychedelics research gains support from the Trump administration for treating PTSD and mental health conditions, with Veterans Affairs exploring treatments that show promise in clinical trials.

CPT is also one of the most widely studied treatments for PTSD, with strong outcomes across diverse populations, including veterans, survivors of sexual assault, and people with multiple traumas.